The landscape of gMG treatment is rapidly evolving, said John Morren, MD, of the Cleveland Clinic. The traditional approach ...

Objectives Smoking is a well-established risk factor that exacerbates multiple sclerosis (MS) progression and increases disease activity. Smoking cessation promotion practices of MS clinicians are not ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous ...

NMO may be confused with multiple sclerosis. But MS is different. The two diseases have similar symptoms, but the symptoms are usually more severe with NMO. There are two types of neuromyelitis ...

NASHVILLE, Tennessee— Neuromyelitis optica spectrum disorder (NMOSD) is quite rare; it is believed to affect only 22,000 people in the US. By comparison, more than 900,000 Americans have multiple ...

Neuromyelitis Optica Spectrum Disorder: Management Essentials for MS Clinics This activity is supported by educational funding provided by Amgen.

The FDA has approved Ultomiris (ravulizumab-cwvz) for patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 (AQP4) antibody positive.

Neuromyelitis optica, or NMO, is also called neuromyelitis optica spectrum disorder (NMOSD) and Devic disease. It is a disease that affects your eyes and spinal cord. It's not very common -- only ...

Some of the symptoms commonly associated with neuromyelitis optica are similar to MS, which can lead to misdiagnosis among Asian Americans and subsequently low and inaccurate incidence and ...

It can look like multiple sclerosis (MS), act like MS, and feel like MS. And until recently, neuromyelitis optica spectrum disorder (NMOSD) was often misdiagnosed as MS, a situation that could ...